A new objective method for evaluating muscle relaxants in congenital spastic diplegia.
D002753:Chlorzoxazone; D006801:Humans; D009128:Muscle Spasticity / Q000151:congenital*; D009132:Muscles / Q000627:therapeutic use*; D010919:Placebos; D012119:Respiration / Q000187:drug effects; D013147:Spirometry
D010919:Placebos; D002753:Chlorzoxazone